Sesconoa Tablet

Adult dose

Take one tablet daily for 21 days and then take a break for 7 days. It is advisable to take it at the same time every day. If taking for the first time, start taking from the first day of menstruation for 21 consecutive days and then take a 7-day break. For continuous use, after a 7-day break, resume the next day. If a dose is missed, take the missed tablet immediately upon remembering and continue as per the usual schedule.

This medicine can significantly increase the risk of serious cardiovascular side effects, particularly thrombosis, in women who smoke. Women over the age of 35 should avoid smoking, and smokers over 35 should not take this medicine. This medicine should not be administered to patients with certain conditions. For example, patients with estrogen-dependent tumors or breast cancer, those with a history of thromboembolic disorders, cardiovascular disease, moderate to severe hypertension, liver disease, pregnant women, or women who may become pregnant should avoid taking this medicine as it may pose risks. Caution is required when administering this medicine to smokers, patients with hypertension, obese individuals, women over 40, patients with epilepsy or migraines, and those with a family history of breast cancer. While taking this medicine, there is a possibility of cardiovascular adverse reactions such as thrombosis, stroke, and myocardial infarction, so care is needed. Various side effects may be reported, including menstrual irregularities, breast pain, gastrointestinal issues, headaches, skin rashes, and visual disturbances. During treatment, regular checks of blood pressure, breast, and cervical status should be carried out, and if there are risk factors for thrombosis, monitoring should be even more rigorous. This medicine may interact with other medications, so if there are other drugs being taken, it is essential to consult a doctor or pharmacist. In particular, the contraceptive effect may be reduced when combined with anticonvulsants, antibiotics, certain antiviral drugs, and some epilepsy medications. Pregnant women or those suspected of being pregnant should not take this medicine, and nursing mothers should also avoid it. In case of overdose, symptoms such as nausea, vomiting, dizziness, and drowsiness may occur, and there is no specific antidote, so treatment should be provided according to the symptoms. This medicine should be kept out of the reach of children and stored in its original container. During treatment with this medicine, it is advisable to avoid smoking and to undergo regular check-ups and careful monitoring. If any abnormal symptoms arise, consult a doctor immediately.

Serious side effects

• Urticaria
• angioedema
• severe allergic reactions
• thromboembolic venous disease
• thrombosis
• arterial thromboembolism
• stroke
• cerebral hemorrhage
• cerebral thrombosis
• myocardial infarction

Mild side effects

• Irregular menstrual bleeding
• changes in menstrual volume
• amenorrhea
• vaginal discharge changes
• increase in size of uterine fibroids
• cervical erosion
• vaginal candidiasis
• vaginitis
• premenstrual syndrome
• dysmenorrhea

Drug interactions

This medicine interacts with direct-acting antiviral agents for hepatitis C, barbiturates, anticonvulsants (carbamazepine, phenytoin, primidone), rifabutin, rifampicin, ampicillin, tetracycline, griseofulvin, loperamide, aprepitant, bosentan, efavirenz, felbamate, oxcarbazepine, medicinal charcoal, laxatives, beta-blockers (such as metoprolol), benzodiazepines, cyclosporine, and ritonavir.

This medicine is sensitive to light and should be stored in a container that does not allow light to enter. Additionally, it is important to store the medicine at room temperature, between 1 to 30 degrees Celsius, where the temperature is neither too high nor too low.

Appearance

Pink round film-coated tablet

Package unit

21 tablets (21 tablets/PTP X 1)